May 08, 2013
The proposed order would reclassify sunlamp products from Class 1 to Class 2 medical devices and require the devices undergo premarket FDA review.
April 16, 2013
The incidence of pediatric melanoma has increased by about 2% per year since 1973.
April 09, 2013
One-in-four melanoma survivors report they do not wear sunscreen when going outside on a warm sunny day.
April 08, 2013
Researchers suggest cancer events be routinely reported in future trials of the antiarrythmia drug and call for additional observational studies.
April 03, 2013
The depression and anxiety medication duloxetine is effective in reducing pain in patients with chemotherapy-induced peripheral neuropathy.
October 17, 2012
Multitarget stool DNA-based test has a 98% sensitivity for detecting colorectal cancer.
October 15, 2012
The FDA has approved protein-bound paclitaxel as a treatment for patients with non-small cell lung cancer who are not candidates for surgery or radiation.
October 01, 2012
A patient has elevated creatine and fasciculations. Could an electrolyte imbalance be the cause?
September 13, 2012
Choline C 11 Injection, a PET scan imaging agent, is now available for men with elevated PSA levels after earlier treatment for prostate cancer.
September 11, 2012
Lack of cancer expertise, continuity of care cited as barriers to receiving follow-up cancer care from primary care providers.
July 31, 2012
HPV DNA testing at baseline predicted progression to cervical intraepithelial neoplasia grade 3 at 18-year follow-up more accurately than Pap smear.
July 25, 2012
Melanoma risk increases with each additional session of sunbed use per year, and for those whose first use was before age 35 years.
June 29, 2012
Recommending fecal occult blood testing as an alternative to colonoscopy could increase colorectal cancer screening compliance.
June 13, 2012
A novel cannabinoid formulation, nabiximols, is safe and effective for patients with advanced cancer and opioid-refractory pain, especially at a low-dose.
Based on the evidence, the U.S. Preventive Services Task Force gave a grade D recommendation against PSA-based screening for men in the general U.S. population, regardless of age.
May 09, 2012
Counseling moderately increases the use of sun-protective behaviors in 10- to 24-year-old patients who are at high risk for skin cancer.
The FDA is notifying healthcare providers about an increased risk for second primary malignancies in patients with newly-diagnosed multiple myeloma who received Revlimid (lenalidomide capsules; Celgene).
May 01, 2012
Brachytherapy is associated with more complications, but no difference in overall survival compared with whole-breast irradiation after lumpectomy in older women with invasive breast cancer.
May 01, 2012
Women with extremely dense breasts and those with a first-degree relative with breast cancer may benefit from biennial mammography starting at age 40 years.
April 20, 2012
Additional surveillance and methodology are needed to assess the impact of HPV vaccines on disease incidence going forward.
April 03, 2012
Ongoing use of combined hormone therapy for 10 years or longer doubled the risk for breast cancer.
Regular aspirin use significantly the reduced risk for cancer, metastasis and cancer mortality, findings from three analyses published in Lancet and Lancet Oncology indicate.
February 16, 2012
Women who develop problematic hot flashes after breast cancer treatment, a contraindication for hormone replacement therapy, experienced significant improvement in quality of life after receiving behavioral therapy.
The FDA is warning health care professionals about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.
February 02, 2012
The FDA expanded indications for imatinib mesylate tablets (Gleevec, Novartis) to include patients who have had CD117-positive gastrointestinal stromal tumors surgically removed.
January 08, 2012
Type 2 diabetes has a greater effect on cancer outcomes than on the risk of incident cancer
December 22, 2011
Highest risk seen for patients with previous diagnosis of cutaneous melanoma
Fentanyl nasal spray is indicated for breakthrough pain in opioid-tolerant patients who are already receiving and tolerant to continuous opioid therapy for underlying persistent cancer pain.
December 14, 2011
More than half adults older than 75 years are still screened for prostate, colorectal, breast and cervical cancers, with clinician recommendation for specific tests among the greatest predictors of screening.
December 13, 2011
Women with low-grade cancer tumors who increased their starch intake 5-g per day upped their recurrence risk 3%.
